Cattlemen for Cancer Research slates annual auction benefiting...
Cattlemen for Cancer Research (CCR) will hold its 20th annual auction in Bastrop, Texas, Saturday, Oct. 20, at the Hills Prairie...
Vaccine, anti-PD1 drug show promise against incurable...
A tumor-specific vaccine combined with an immune checkpoint inhibitor shrank tumors in one third of patients with incurable cancer...
A Conversation With a Living Legend in Dallas to honor major...
A Conversation With a Living Legend® in Dallas will honor PGA TOUR professional Jordan Spieth, Nov. 5 at the Hilton Anatole. CBS...
Poziotinib maintains high response rate against harmful lung...
A drug revived by researchers at The University of Texas MD Anderson Cancer Center continues to provide unprecedented response rates...
MD Anderson hosts Biden Cancer Community Summit
The University of Texas MD Anderson Cancer Center today joined with more than 450 communities and institutions across the country in...
Largest-Ever Study Shows Silicone Breast Implants...
In the largest study of long-term safety outcomes for patients with breast implants, researchers at The University of Texas MD...
Rogers Award honors Padmanee Sharma, M.D., Ph.D., for excellence...
Padmanee Sharma, M.D., Ph.D., is the 2018 recipient of the Julie and Ben Rogers Award for Excellence in Research at The University of...
MD Anderson immunotherapy expert Sharma wins Coley Award
Padmanee Sharma, M.D., Ph.D., professor of Genitourinary Medical Oncology and Immunology at The University of Texas MD Anderson...
Study links BAP1 protein to tumor suppression in kidney,...
Researchers at The University of Texas MD Anderson Cancer Center have shown how BRCA-associated protein 1 (BAP1) serves as a tumor...
Study finds no difference in disease-free, overall survival...
New research in women with HER2+ breast cancer found no difference in disease-free survival (DFS) and overall survival (OS) when...
Poziotinib sustains high response rates against intractable...
A drug revived by researchers at The University of Texas MD Anderson Cancer Center continues to provide high response rates among...